evolution of incretin-based therapies : From CLP-1 monotherapy to dual and triple agonists : a new era in metabolic therapy

Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5627

Title:	evolution of incretin-based therapies : From CLP-1 monotherapy to dual and triple agonists : a new era in metabolic therapy
Authors:	Monika Gupta
Keywords:	Incretin therapy MASH Metabolic Sydrome Type 2 diabetes
Issue Date:	8-Jul-2026
Description:	Vol. 163, No. 4, p 427
URI:	http://111.93.178.142:25000/jspui/handle/123456789/5627
Appears in Collections:	Vol. 163, No.4, 2026

Files in This Item:

File	Description	Size	Format
1.pdf	Vol. 163, No. 4, p 427	157.48 kB	Adobe PDF	View/Open

DSpace JSPUI